The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Korotkov A.G.

Razumovskiy Saratov State Medical University, Saratov, Russia

Muzalevskaia D.S.

Razumovskiy Saratov State Medical University, Saratov, Russia

Kolokolov O.V.

Saratovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. V.I. Razumovskogo Minzdravsotsrazvitiia Rossii

A role of antioxidants in the complex treatment of epilepsy

Authors:

Korotkov A.G., Muzalevskaia D.S., Kolokolov O.V.

More about the authors

Read: 15109 times


To cite this article:

Korotkov AG, Muzalevskaia DS, Kolokolov OV. A role of antioxidants in the complex treatment of epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9‑2):44‑48. (In Russ.)
https://doi.org/10.17116/jnevro20161169244-48

Recommended articles:
Febrile infe­ction-related epilepsy syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):34-40
Therapies for focal epilepsy asso­ciated with brain tumors. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):14-20
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138

References:

  1. Dzayk LA, Zenkov, Kirichenko AG, Epilepsy. Kiev; 2001.
  2. Zavalishin IA, Zakharova MN. Astroglia: functional aspects. Neuroimmunology. SPb.; 1996.
  3. O'Muircheartaigh J, Vollmar C, Barker GJ, Kumari V, Symms MR, Thompson P, Duncan JS. Focal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy. Neurology. 2011;76(1):34-40. doi: 10.1212/WNL.0b013e318203e93d
  4. Karlov VA. Epilepsy in children and adult women and men: a manual for physicians. M.: Meditsina; 2010.
  5. Sazgar M, Bourgeois BF. Аggravation of epilepsy by antiepileptic drugs. Journal Pediatric Neurology. 2005;33(4):227-234. doi.org/10.1016/j.pediatrneurol.2005.03.001
  6. Avakian GN. Materials of international conference «Epilepsy: medical and social aspects, diagnosis and treatment». M. 2005;46-54.
  7. Penfield W, Erickson T. Epilepsy and cerebral localization. M. 1949.
  8. Jokeit H, Ebner A. The risk of cognitive decline in patient with refractory temporal lobe epilepsy. Cambridge; 2002. doi.org/10.1017/CBO9780511544354.011
  9. Avakian G.G. Clinical and neurophysiological study of combinations of new forms of anticonvulsants and antioxidants in patients with epilepsy with secondary generalized seizures»: author's abstract of dissertation on competition of a scientific degree of candidate of medical Sciences. M. 2011. Active on 28.07.16. Available at: http://www.dissercat.com/content/kliniko-neirofiziologicheskoe-izuchenie-kombinatsii-novykh-form-antikonvulsantov-i-antioksid
  10. Avakian GG, Nerobkova LN, Oleynikova, OM, Voronina TA, Avakyan GN, Gusev EI. Application valproat and antioxidant in case of secondary generalized seizures. Epilepsy and paroxysmal States. 2011;3(2):34-44.
  11. Litvinovich EF. Clinical and pharmacoeconomic effectiveness of antioxidant Mexidol in the combined pathogenetic therapy of patients with symptomatic focal epilepsy. Bulletin of experimental biology and medicine. 2006;(suppl 1):45-47.
  12. Korotkov AG. the use of the drug «Mexidol in complex treatment of patients with pharmacoresistant partial epilepsy. Bulletin of experimental biology and medicine. 2006;(suppl 1):34-36.
  13. Odinak MM, Dyskin DE. Epilepsy: etiology, clinic, differential diagnostics, medical treatment. SPb.: Polytechnic; 1997.
  14. Forsgren L, Bucht G, Eriksson S et al. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population based study. Epilepsia. 1996;37:224-229. doi: 10.1111/j.1528-1157.1996.tb00017.x
  15. Hauser WA, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia. 1975;16:61-66. doi: 10.1111/j.1528-1157.1975.tb04721.x
  16. Danilova TV, Khasanova DR, Kamalov IR. post-stroke epilepsy: predatory, risk factors, clinical variants, treatment. Journal of Neurology, neuropsychiatry, psychosomatics. 2012;1:82-87. doi.org/10.14412/2074-2711-2012-367
  17. Kalinin VV, Zheleznova EV, Sokolova LV. et al. Mental disorders in epilepsy. Manual for doctors. M.: Print city; 2006.
  18. Kalinin VV. the Psychiatric issues of epilepsy and psychiatry. Social and wedge psychiatrist. 2003;3:5-11.
  19. Trimble M, Schmitz B. Seizures, Affective Disorders and Anticonvulsant Drugs. Clarus Press Ltd, Guildford, UK; 2002.
  20. Novikov VE, Maslova NN. The effect of Mexidol on the course of post-traumatic epilepsy. Experimental and clinical pharmacology. 2003;66(4):9-11.
  21. Avakian GN, Voronina TA, Garibova TL, etc., 2nd East-European conference «Epilepsy and clinical neurophysiology». Zaporozhye; 2010;260-261.
  22. Badalyan OL, Avakyan GN, Voronina TA, Nerobkova LN. The possibility of using the combination of carbamazepine and Mexidol in adolescents with partial epilepsy 2nd Eastern European conference «Epilepsy and clinical neurophysiology». Zaporozhye; 2010;189-190.
  23. Loshakov VA, Youssef ES, Likhterman LB. et al. Diagnosis and surgical treatment of post-traumatic hydrocephalus. Journal Questions neurosurgery them. N.N. Burdenko. 1993;3:18-22
  24. Savenkov AA, Badalyan OL, Avakyan GN. Application of nootropics and antioxidants in the complex therapy of symptomatic posttraumatic epilepsy. Journal of Neurology and Psychiatry. 2013;6:26-34.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.